Astrocytoma medical therapy: Difference between revisions

	Astrocytoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Astrocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Study
Case #1
Astrocytoma medical therapy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Astrocytoma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Astrocytoma medical therapy
CDC on Astrocytoma medical therapy
Astrocytoma medical therapy in the news
Blogs on Astrocytoma medical therapy
Directions to Hospitals Treating Astrocytoma
Risk calculators and risk factors for Astrocytoma medical therapy

Revision as of 13:04, 20 August 2015

Despite decades of therapeutic research, curative intervention is still nonexistent for high grade astrocytomas; patient care ultimately focuses on palliative management.

Revision as of 13:04, 20 August 2015 view source Ammu Susheela (talk \| contribs) nocaptcha, Administrators 14,466 edits No edit summary ← Older edit		Revision as of 13:04, 20 August 2015 view source Ammu Susheela (talk \| contribs) nocaptcha, Administrators 14,466 edits No edit summary Newer edit →
Line 4:		Line 4:
	==Medical Therapy==		==Medical Therapy==

	* For low grade astrocytomas, removal of the tumor will generally allow functional survival for many years. In some reports, the five-year survival has been over 90% with well resected tumors. Indeed, broad intervention of low grade conditions is a contested matter. In particular, [[pilocytic astrocytoma]]s are commonly indolent bodies that may permit normal neurologic function. However, left unattended these tumors may eventually undergo neoplastic transformation. To date, complete resection of high grade astrocytomas is impossible because of the diffuse infiltration of tumor cells into normal parenchyma. Thus, high grade astrocytomas inevitably recur after initial surgery or therapy, and are usually treated similarly as the initial tumor. Despite decades of therapeutic research, curative intervention is still nonexistent for high grade astrocytomas; patient care ultimately focuses on [[palliative]] management.		* Despite decades of therapeutic research, curative intervention is still nonexistent for high grade astrocytomas; patient care ultimately focuses on [[palliative]] management.